Daniel Bauer
Impact in
- Dermatology top 5%
- Contact Dermatitis and Allergies
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Skin Protection and Aging 3
-
- Pharmacovigilance and Adverse Drug Reactions 3
- Co-authors
- Andreas Gansäuer (2 shared papers)G. F. Kahl (3 shared papers)Karen Ildico Hirsch‐Ernst (3 shared papers)Herbert Desel (1 shared paper)Alex Odermatt (2 shared papers)Ulla Plappert‐Helbig (1 shared paper)Heidrun C. Ellinger-Ziegelbauer (2 shared papers)Betty A. Pettersen (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (4 papers)Regulatory Toxicology and Pharmacology (3 papers)Toxicological Sciences (3 papers)European Journal of Organic Chemistry (2 papers)Molecular Pharmacology (2 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Daniel Bauer
21 papers receiving 695 citations
Daniel Bauer's Hit Papers
Peers
Comparison fields: 5 of 65
- Dermatology 80
- Pharmacology 56
- Cancer Research 75
- Cell Biology 70
- Toxicology 22
Countries citing papers authored by Daniel Bauer
This map shows the geographic impact of Daniel Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Bauer more than expected).
Fields of papers citing papers by Daniel Bauer
This network shows the impact of papers produced by Daniel Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Bauer. The network helps show where Daniel Bauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Bauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 166 | |
| 2 | Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers Hit paper breakdown → | 2024 | 99 |
| 3 | 2012 | 73 | |
| 4 | 2009 | 56 | |
| 5 | 1998 | 48 | |
| 6 | 1998 | 41 | |
| 7 | 2001 | 39 | |
| 8 | 2004 | 37 | |
| 9 | 2020 | 35 | |
| 10 | 2013 | 24 | |
| 11 | 2013 | 22 | |
| 12 | 2011 | 21 | |
| 13 | 2014 | 20 | |
| 14 | 2023 | 12 | |
| 15 | 2001 | 11 | |
| 16 | 2014 | 11 | |
| 17 | 2011 | 9 | |
| 18 | 2016 | 8 | |
| 19 | 2019 | 7 | |
| 20 | 2021 | 6 |
About Daniel Bauer
Daniel Bauer is a scholar working on Dermatology, Toxicology, Pharmacology, Small Animals and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 747 indexed citations. Recurring topics across this work include Photodynamic Therapy Research Studies (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Skin Protection and Aging (3 papers), Carcinogens and Genotoxicity Assessment (2 papers), Photochemistry and Electron Transfer Studies (2 papers), Animal testing and alternatives (2 papers) and Radical Photochemical Reactions (2 papers). The work is most often cited by research in Dermatology (80 citations), Pharmacology (56 citations), Cancer Research (75 citations), Cell Biology (70 citations) and Toxicology (22 citations). Daniel Bauer has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Andreas Gansäuer, G. F. Kahl, Karen Ildico Hirsch‐Ernst, Herbert Desel, Alex Odermatt, Ulla Plappert‐Helbig, Heidrun C. Ellinger-Ziegelbauer, Betty A. Pettersen, Yi-Zhong Gu and Catherine Spire. Their work appears in journals such as Journal of Medicinal Chemistry, Regulatory Toxicology and Pharmacology, Toxicological Sciences, European Journal of Organic Chemistry and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.